Retinitis


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

retinitis

[‚ret·ən′īd·əs]
(medicine)
Inflammation of the retina.

Retinitis

 

inflammation of the retina, generally in both eyes. It results from purulent infection of the retinal vessels caused by sepsis, a purulent focus, tuberculosis or other infectious diseases, or poisoning. Retinitis is usually accompanied by inflammation of the choroid (chorioretinitis). A characteristic development is the appearance of scotomata, or areas of depressed vision within the visual field that correspond to the inflammatory focus in the fundus of the eye. If treatment is inadequate, the depression of vision becomes permanent. Treatment depends on the causative disease.

References in periodicals archive ?
PIONEER is a first-in-man, multi-center, open label dose-escalation study to evaluate the safety and tolerability of GS030 in subjects affected by end-stage non-syndromic retinitis pigmentosa with vision not better than "counting fingers.
This family showing a clear pattern of early onset retinitis pigmentosa was checked through linkage analysis against the known genes by using the STS markers.
Table: Identified Retinitis pigmentosa genetic mutations in South Asia.
Retinitis Pigmentosa (Retinitis) - Therapeutics under Development by Companies 11
In this report, we highlight the three patients in this cohort who developed CMV retinitis.
Presumed CMV retinitis was diagnosed on the characteristic clinical appearance on ophthalmoscopy.
Its approach to gene therapy uses a viral vector known as adeno-associated virus (AAV), which delivers a codon-optimised copy of the retinitis pigmentosa GTPase regulator (RPGR) gene into cells of the eye.
Twenty one patients presented with CMV retinitis in our study.
Types of genetic eye disorders had 10 attributes; Strabismus, cataract, extreme myopia, anophthalmia, microphthalmia, astigmatism and nystagmus, keratoconus, glaucoma and retinitis pigmentosa.
Retinitis Pigmentosa (RP) is a group of rare, inherited genetic disorders characterized by progressive peripheral vision loss and night vision difficulties followed by eventual central vision loss and blindness in many cases.
The report provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination.